Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

FDA Approves Teva's Once-Monthly Injectable Olanzapine

(RTTNews) - Friday, Teva Pharmaceuticals (TEVA) announced that the U.S. FDA has approved WELTRUZA (olanzapine) extended-release injectable suspension for adults with schizophrenia.

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at nasdaq.com →

More in Health & Medicine

More from Friday 9 October →